For: | Bajer L, Slavcev A, Macinga P, Sticova E, Brezina J, Roder M, Janousek R, Trunecka P, Spicak J, Drastich P. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease. World J Gastroenterol 2018; 24(43): 4939-4949 [PMID: PMC6250922 DOI: 10.3748/wjg.v24.i43.4939] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i43/4939.htm |
Number | Citing Articles |
1 |
Atsushi Tanaka, Hajime Kono, Patrick S.C. Leung, M. Eric Gershwin. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cellular Immunology 2020; 347: 104021 doi: 10.1016/j.cellimm.2019.104021
|
2 |
Atsushi Tanaka, Patrick S.C. Leung, M. Eric Gershwin. Autoimmune Liver Disease. 2020; : 247 doi: 10.1002/9781119532637.ch14
|
3 |
Paulo Lisboa Bittencourt, Mateus Jorge Nardelli, Luísa Leite Barros, Guilherme Grossi Lopes Cançado, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela‐Nogueira, Maria Lucia Gomes Ferraz, Liana Codes, Vivian Rotman, Rodrigo Rocco, Guilherme Eduardo Felga, Diogo Delgado Dotta, Adrielly de Souza Martins, Liliana Sampaio Costa Mendes, Marlone Cunha da Silva, Elodie Bonfim Hyppolito, Geisa Perez Medina Gomide, Izabelle Venturini Signorelli, Maria Beatriz de Oliveira, Claudia Alexandra Pontes Ivantes, Maria Chiara Chindamo, Valéria Ferreira de Almeida e Borges, Luciana Costa Faria, Claudia Alves Couto. Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium. Clinical Transplantation 2024; 38(10) doi: 10.1111/ctr.70002
|
4 |
Julien Vionnet, Alberto Sanchez-Fueyo, James Neuberger. Liver Immunology. 2020; : 597 doi: 10.1007/978-3-030-51709-0_36
|
5 |
E. S. Pak, T. M. Petrova, R. V. Korobka, A. A. Ushakov, O. B. Kucherenko, V. Yu. Katsiyaev, O. V. Bukhtin. Recurrence of primary sclerosing cholangitis in the graft. Medical Herald of the South of Russia 2024; 15(3): 97 doi: 10.21886/2219-8075-2024-15-3-97-105
|
6 |
Marina Berenguer, Eleonora de Martin, Amelia J. Hessheimer, Josh Levitsky, Daniel G. Maluf, Valeria R. Mas, Nazia Selzner, Helena Hernàndez-Èvole, Alina Lutu, Nabeel Wahid, Haseeb Zubair. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation. Transplant International 2023; 36 doi: 10.3389/ti.2023.11358
|
7 |
|
8 |
Ari Garber, Miguel Regueiro. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Current Gastroenterology Reports 2019; 21(7) doi: 10.1007/s11894-019-0698-1
|
9 |
Chongfa Chen, Ruisheng Ke, Fang Yang, Qiucheng Cai, Jianyong Liu, Xinghua Huang, Jianwei Chen, Fengfeng Xu, Yi Jiang. Risk factors for recurrent autoimmune liver diseases after liver transplantation. Medicine 2020; 99(20): e20205 doi: 10.1097/MD.0000000000020205
|
10 |
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
|
11 |
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseases. World Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
|